Our commitment to quality: batch by batch

Avextra offers high-quality cannabis-based medicines. Our strength lies within our cultivation in Portugal and the combination of traditional and high-tech extraction methods in Germany. Discover more insights from our CMO David Reckeweg-Lecompte by watching this video.

Podcasts

Neil Smith featured on Planted with Sara Payan.

Sara discusses the European cannabis landscape and new movement in R&D with Neil Smith, COO of German bio-pharmaceutical company Avextra.

Press Releases

Please find the latest press releases from Avextra here.

Medical Device Submission for a Cannabis Extract Inhaler

Medical Device Submission for a Cannabis Extract Inhaler

Avextra has commissioned the Leading Medical Device Specialists Activoris and Actarmo to prepare the EU Medical Device Submission for a Cannabis Extract Inhaler Together these three partners will develop a…

Eurox has rebranded as Avextra

Eurox has rebranded as Avextra

Bensheim, 14.9.2022 – Der führende Anbieter von cannabisbasierten Arzneimitteln aus Deutschland mit neuem Namen: Aus Eurox wird Avextra. Avextra stellt sich vom 14. bis zum 17. September 2022 auf dem…

Neues Vorstandsmitglied bei der Eurox AG: Marla Luther ist Chief Strategy Officer

Neues Vorstandsmitglied bei der Eurox AG: Marla Luther ist Chief Strategy Officer

Marla Luther ist neue Chief Strategy Officer bei Eurox Pharma, dem führenden europäischen vertikal-integrierten Hersteller von cannabis-basierten Arzneimitteln, welcher künftig unter dem Namen Avextra firmieren wird. Zum Artikel

Saarbrücker Zeitung: Neues Vorstandsmitglied bei der Eurox AG: Marla Luther

Saarbrücker Zeitung: Neues Vorstandsmitglied bei der Eurox AG: Marla Luther

Marla Luther ist neue Chief Strategy Officer bei Eurox Pharma, dem führenden europäischen vertikal-integrierten Hersteller von cannabis-basierten Arzneimitteln, welcher künftig unter dem Namen Avextra firmieren wird. Zum Artikel

Eine Spritze voller Cannabis – FAZ

Eine Spritze voller Cannabis – FAZ

Die kleine Spritze ist potent. Gerade mal ein Gramm an einer öligen Flüssigkeit ent­hält sie, doch das reicht, um Patienten bis zu 200 Dosen an Dronabi­nol zu verabreichen, einem Wirkstoff,…

Gute Geschäfte mit Gras – Metropol April/Mai 2022

Gute Geschäfte mit Gras – Metropol April/Mai 2022

Seit fünf Jahren darf Medizinalcannabis an Patienten verschrieben werden. Mehrere Start-ups aus Rhein-Main sind seit Anbeginn dabei – und hoffen auf die weitere Legalisierung. Zum Artikel

Neues Kapital in Höhe von 4,4 Mio Euro

Neues Kapital in Höhe von 4,4 Mio Euro

Bensheim, 06. April 2022 –  Eurox erhält bei Finanzierungsrunde über 4 Millionen Euro für weiteres Wachstum – Neuer Investor Iberis Capital steigt ein […] Weiterlesen

5 Jahre Cannabis-als-Medizin-Gesetz

5 Jahre Cannabis-als-Medizin-Gesetz

Anlässlich des fünfjährigen Bestehens des Cannabis-als-Medizin-Gesetzes zieht das auf Cannabisextrakte und Wirkstoffe spezialisierte Unternehmen mit Wurzeln in der Phytopharmazie eine erste positive Bilanz. „Deutschland hat vor fünf Jahren mutig den…

New board member at Eurox AG: Marla Luther is Chief Strategy Officer

New board member at Eurox AG: Marla Luther is Chief Strategy Officer

Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra name. Full article

A syringe full of cannabis – FAZ

A syringe full of cannabis – FAZ

One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business accomplishments. Full article

Good Business with Grass – Metropol April/May 2022

Good Business with Grass – Metropol April/May 2022

Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further…

Eurox Group raises €4.4M at a significant premium enabling targeted investment – Portuguese Iberis Capital becomes a new institutional investor

Eurox Group raises €4.4M at a significant premium enabling targeted investment – Portuguese Iberis Capital becomes a new institutional investor

As one of the leading European vertically-integrated companies developing and manufacturing cannabis based medicines, Eurox Group, based in Hesse, Germany, has successfully fundraised €4,4 Million from new and existing investors…

5 years of cannabis-as-medicine law

5 years of cannabis-as-medicine law

Eurox Pharma prioritizes research and development. In collaboration with physicians, pharmacists and research, the company aims to produce evidence-based products that meet the specific needs of patients, rather than simply…

Top 16 cannabis startups set to take off in 2022, according to Business Insider

Top 16 cannabis startups set to take off in 2022, according to Business Insider

Last year was the year of megarounds for cannabis startups… Full article

Eurox Pharma is the newest member of the Association of Cannabis Supplying Pharmacies

Eurox Pharma is the newest member of the Association of Cannabis Supplying Pharmacies

Eurox Pharma is a vertically integrated company with roots in the German and European production of herbal medicines. From this tradition, Eurox also ensures the highest quality along the entire…

Medicinical Cannabis made in Germany

Medicinical Cannabis made in Germany

Eurox Pharma manufactures cannabis-based medicines and products in a state-of-the-art facility in Germany. The company relies on cutting-edge research and complies with the highest pharmaceutical quality and safety standards in…

PRESS CONTaCT

Lisa Schwede

Tel.: +49 30 408174037

E-Mail: press@avextra.com

EN